Blackstone Group Inc said on Monday it will invest $400 million in a joint venture with Swiss drug company Ferring that is working on an experimental gene therapy for bladder cancer, the private equity giant's largest ever bet on drug development.
from Reuters: Health News https://ift.tt/33iLkRp
via IFTTT
Monday, November 25, 2019
Home »
Reuters: Health News
» Blackstone to invest $400 million in gene therapy venture with Ferring
0 comments:
Post a Comment